Th1 cell differentiation accelerator
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 19, 2011
Grant Date -
Jul 31, 2008
app pub date -
Nov 14, 2007
filing date -
Dec 8, 2006
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention provides an agent for promoting human Th1 cell differentiation and an agent for suppressing human Th2 cell differentiation, comprising lipoarabinomannans and/or lipomannans derived from BCG cell bodies. The agent of the present invention is useful as a prophylactic/therapeutic agent for cancers and the like, and also as a therapeutic agent for allergic diseases such as pollinosis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully